Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City

International Journal of Tuberculosis and Lung Disease

Volumn 1, Issue 4, 1997, Pages 319-325

  Mannheimer, S B ^a,b   Sepkowitz, K A ^a   Stoeckle, M ^a   Friedman, C R ^a   Hafner, A ^a   Riley, L W ^a  

^a Department of Obstetrics Gynecology   (United States)

^b Columbia University ^*  (United States)

Author keywords

Drug resistance; HIV; MDR TB; Outcome; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; CHILD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; SURVIVAL; TREATMENT OUTCOME; TUBERCULOSIS; UNITED STATES; URBAN POPULATION;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NEW YORK CITY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; URBAN POPULATION;

EID: 0031196722     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jereb J A, Kelly G D, Dooley S W, Cauthen G M, Snider D E. Tuberculosis morbidity in the United States: Final data, 1990. MMWR CDC Surveill Summ 1992; 40 (SS-3): 23-27.
2. Barnes P E, Bloch A B, Davidson P T, Snider D E. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324: 1644-1650.
3. Haas D W, Des Prez R M. Tuberculosis and acquired immunodeficiency syndrome: a historical perspective on recent developments. Am J Med 1994; 96: 439-450.
4. Cantwell M F, Snider D E, Cauthen G M, Onorato I M. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994; 272: 535-539.
5. Selwyn P A, Hartel D, Lewis V A, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
6. Daley C L, Small P M, Schecter G F, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length-polymorphisms. N Engl J Med 1992; 326: 231-235.
7. Small P M, Hopewell P C, Singh S P, et al. The epidemiology of tuberculosis in San Francisco - a population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709.
8. Alland D, Kalkut G E, Moss A R, et al. Transmission of tuberculosis in New York City - an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710-1716.
9. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR 1991; 40: 585-591.
10. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-mfected patients in an urban hospital - Florida. MMWR 1990; 39: 718-722.
11. Frieden T R, Sterling T, Pablos-Mendez A, Kilburn J O, Cauthen G M, Dooley S W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-526.
12. Bloch A B, Cauthen G M, Onorato I M, Dansbury K G, Kelly G D, Driver C R. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994; 271: 665-671.
13. Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system - New York, 1991. MMWR 1992; 41: 507-509.
14. Edlin B R, Tokars J I, Grieco M H, Crawford J T, Williams J, Sordillo E M. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-1521.
15. Fischl M A, Uttamchandani R B, Daikos G L, et al. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992; 117: 177-183.
16. Pearson M L, Jereb J A, Frieden T R, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Ann Intern Med 1992; 117: 191-196.
17. Valway S E, Greifinger R B, Papania M, et al. Multidrug-resistant tuberculosis in the New York state prison system, 1990-1991. J Infect Dis 1994; 170: 151-156.
18. Fischl M A, Daikos G L, Uttamchandani R B, et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med 1992; 117: 184-190.
19. Salomon N, Perlman D C, Friedmann P, Buchstein S, Kreiswirth B N, Mildvan D. Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis 1995; 21: 1245-1252.
20. Turett G S, Telzak E E, Torian L V, et al. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin Infect Dis 1995; 21: 1238-1244.
21. Van Embden J D A, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Micro 1993; 31: 406-409.
22. Friedman C R, Stoeckle M Y, Kreiswirth B N, et al. Transmission of multidrug-resistant tuberculosis in a large urban setting. Am J Respir Crit Care Med 1995; 152: 355-359.
23. Smith P G, Morrow R H; eds. Methods for field trials of interventions against tropical diseases: a toolbox. Oxford: Oxford University Press; 1991: 289-294.
24. Weis S E, Slocum P C, Blais F X, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-1184.